SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is seeing strong community momentum following a joint research agreement with Honda to advance solid-state battery technology and manufacturing processes. Investors and traders are actively discussing the significance of this OEM validation, with many pointing to the partnership as a critical de-risking event that could accelerate commercialization and shift sentiment around the stock.

Roundhill ETF Trust - Roundhill Memory ETF

The DRAM ETF is trending as investors aggressively position themselves for a structural supply shortage in the AI memory market, with community discussion highlighting memory as a critical infrastructure bottleneck rather than a standard cyclical play. Traders are closely monitoring upcoming earnings and the potential for a long-term rerating, driven by sustained demand for high-bandwidth memory (HBM) and supply chain tightness across key industry players.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is surging as investors react to a record-breaking earnings report, highlighted by strong revenue growth and the company's first positive operating cash flow. The community is actively debating the sustainability of this rally, with many focusing on the validation of the company's 'Ultrasound-on-Chip' strategy through high-profile AI partnerships and the potential for a short squeeze given the stock's significant short interest.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accenture is trending as investors grapple with a significant valuation reset following a lowered revenue outlook and concerns over the impact of AI on its core consulting business. The community is sharply divided, with many debating whether the stock is a deep-value opportunity for long-term recovery or if the consulting industry is facing permanent disruption from automated AI solutions.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXTI is trending as investors debate the sustainability of its parabolic rally, fueled by a narrative that indium phosphide (InP) is a critical bottleneck for AI infrastructure. The community remains deeply polarized, with some bulls highlighting the company's vital supply-chain position in high-bandwidth optics, while bears point to aggressive insider selling, potential share dilution, and an extreme valuation relative to recent earnings.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is experiencing renewed bullish momentum as it undergoes a significant breakout on the weekly chart, supported by aggressive store expansion and strong consumer demand. While some community members remain wary of the company's high valuation and competitive headwinds, others are pointing to a classic bottoming setup and positive retail sentiment as key indicators that the stock is poised for further growth.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant attention as investors position for imminent long-term Phase 3 trial data, with community discussion centered on potential M&A catalysts and the stock's positioning within the broader immunology sector. Traders are closely monitoring institutional accumulation patterns and upcoming regulatory conferences for signals that could trigger a major repricing event.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is currently surging on high volume as investors price in aggressive expansion into the weight-loss peptide market and anticipate upcoming regulatory clarity. Community discussion is heavily focused on potential short-squeeze mechanics and the company's long-term growth trajectory, with many traders closely monitoring whether the stock can sustain its momentum above key resistance levels or if it will face a near-term consolidation.

JetBlue Airways Corp. engages in the provision of air transportation services. Its brands include jetBlue, jetBlue Vacations, Paisly, and TrueBlue. It operates through the following geographic segments: Domestic and Canada, Caribbean and Latin America, and Atlantic. The company was founded by David Gary Neeleman in August 1998 and is headquartered in Long Island City, NY.

Jetblue Airways Corp

JetBlue is experiencing significant volatility and increased investor interest following reports that the airline has retained advisors to explore a potential sale or merger. The community is actively debating the likelihood of an acquisition by a major carrier like United Airlines versus concerns regarding the company's long-term debt and the broader financial pressures facing the airline industry.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is currently capturing market attention as investors monitor its progress in transitioning from a research-focused entity to a commercial player within the AI and high-speed data center infrastructure sector. Community discourse remains heavily centered on the company's strategic partnerships with foundries and the anticipation of material supply or licensing agreements that could validate its electro-optic polymer technology for high-volume production.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GW is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, EPIDIOLEX (cannabidiol) oral solution, is commercialized in the U.S. by its U.S. subsidiary Greenwich Biosciences for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in patients one year of age and older. This product has received approval in the European Union under the tradename EPIDYOLEX for the adjunctive treatment of seizures associated with LGS or Dravet syndrome in conjunction with clobazam in patients two years and older and is under EMA review for the treatment of TSC. The Company has a deep pipeline of additional cannabinoid product candidates, in particular nabiximols, for which the Company is advancing multiple late-stage clinical programs in order to seek FDA approval in the treatment of spasticity associated with multiple sclerosis and spinal cord injury. The Company has additional cannabinoid product candidates in clinical trials for autism and schizophrenia.

GW Pharmaceuticals - ADR

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

GWPHGW Pharmaceuticals plc

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest GWPH News